Journal of Mass Spectrometry and Advances in the Clinical Lab (JMSACL)

Journal of Mass Spectrometry and Advances in the Clinical Lab (JMSACL) is an international, peer-reviewed, fully open-access journal dedicated to advancing the application of mass spectrometry and emerging analytical technologies in clinical laboratory medicine and pathology. Established under its current title in 2021 as the successor to Clinical Mass Spectrometry, the journal serves as the official publication of the Association for Mass Spectrometry: Applications to the Clinical Lab (MSACL). It provides a multidisciplinary platform for clinical chemists, pathologists, laboratory physicians, analytical chemists, biomedical scientists, and healthcare researchers. The journal publishes original research articles, reviews, mini-reviews, technical reports, clinical case studies, guidelines, tutorials, editorials, and opinion papers. Its scope includes clinical mass spectrometry, proteomics, metabolomics, lipidomics, glycomics, therapeutic drug monitoring, toxicology, endocrinology, microbiology, neonatal screening, laboratory automation, quality management, diagnostic biomarkers, molecular diagnostics, imaging, data science, and translational laboratory medicine. The journal emphasizes validated analytical methods and technologies that improve diagnostic accuracy, laboratory efficiency, patient outcomes, and healthcare cost-effectiveness. JMSACL is indexed in major databases including PubMed Central (PMC), Scopus, Embase, DOAJ, and the Science Citation Index Expanded (SCIE), making it an important resource in laboratory medicine and clinical diagnostics.

Journal of Mass Spectrometry and Advances in the Clinical Lab (JMSACL) is :-

• International, Peer-Reviewed, Open Access, Refereed, Clinical Mass Spectrometry, Clinical Laboratory Medicine, Clinical Pathology, Analytical Chemistry, Proteomics, Metabolomics, Lipidomics, Glycomics, Therapeutic Drug Monitoring, Toxicology, Laboratory Automation, Data Science in Laboratory Medicine, Molecular Diagnostics, Biomarker Discovery, clinical mass spectrometry, proteomics, metabolomics, lipidomics, glycomics, therapeutic drug monitoring, toxicology, endocrinology, microbiology, neonatal screening, laboratory automation, quality management, diagnostic biomarkers, molecular diagnostics, imaging, data science, translational laboratory medicine , Online or Print , Continuously Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 2667-1468, E-ISSN: 2667-145X, Established: 2021,
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE